On:

Dr. Oz again took aim at his U.S. Senate opponent over his support for marijuana legalization—but, after being pressed on his past comments on the issue, he conceded that, yes, he’s personally in favor of medical cannabis, saying that it’s a “safer solution” compared to certain prescription drugs like opioids.Continue Reading

On:

A top federal health official says marijuana research is “fraught with hurdles”—including its continued prohibition under federal law—that need to be addressed in order to unlock studies on areas such as how cannabinoids can serve as “safer tools” than opioids in managing pain. National Center for Complementary and Integrative HealthContinue Reading

On:

Not long after its launch in 1844, Pabst Brewing Company started winning awards in world and US competitions. To commemorate their victories, a blue ribbon was added to the bottlenecks of the American lager. In 1899 the brand was officially dubbed “Pabst Blue Ribbon” after selling 100 million barrels. OverContinue Reading

On:

Missouri activists announced on Thursday that they have launched a campaign to oppose a marijuana legalization initiative that will be on the November ballot, calling on the governor to give lawmakers a chance to enact reform during an upcoming special session. The “No On Amendment 3—Missouri Deserves Better” campaign isContinue Reading

On:

AB 2188 heads to Gov. Newsom’s desk. It could change how employers use urine drug tests against their workers. The post Cannabis users’ right to work law advances in California appeared first on Leafly. Read More: Cannabis users’ right to work law advances in CaliforniaContinue Reading

On:

The pharmaceutical industry takes a serious economic hit after states legalize marijuana—with an average market loss of nearly $10 billion for drugmakers per each legalization event—according to a first-of-its-kind study. The peer-reviewed research article, published in the journal PLOS ONE on Wednesday, looked at stock return and prescription drug salesContinue Reading